Sigma Planning Corp Affimed N.V. Transaction History

Sigma Planning Corp

  • $3.22 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$7.78 - $11.4 $84,202 - $123,382
-10,823 Closed
0 $0
Q1 2021

May 06, 2021
BUY
$5.12 - $8.48 $55,413 - $91,779
10,823 New
10,823 $86,000
Q2 2019

Aug 01, 2019
SELL
$2.6 - $4.21 $28,210 - $45,678
-10,850 Closed
0 $0
Q1 2019

May 01, 2019
BUY
$3.05 - $4.34 $33,092 - $47,089
10,850 New
10,850 $46,000

Others Institutions Holding AFMD

# of Institutions
3
Shares Held
1.09M
Call Options Held
0
Put Options Held
0
View Full List

About Affimed N.V.

AFMD Quotes by TradingView
  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $520M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email